Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Samuel G.W. Ow"'
Autor:
Dario Campana, Boon Cher Goh, Priscillia J.X. Koe, Jedidah L.M. Lieow, Nesaretnam Barr Kumarakulasinghe, Wan Qin Chong, Hon Lyn Tan, Raghav Sundar, Elaine Coustan-Smith, Mabel Z.Q. Foo, Yoon Sim Yap, Lavina Bharwani, Samuel G.W. Ow, Sing Huang Tan, Michelle L.M. Poon, Liang Piu Koh, Lip Kun Tan, Wei Peng Yong, Kritika Yadav, Andrea Wong, Joline S.J. Lim, Noriko Shimasaki, Soo-Chin Lee
Purpose:Natural killer (NK) cells exert antibody-dependent cell cytotoxicity (ADCC). We infused expanded, activated autologous NK cells to potentiate trastuzumab-mediated ADCC in patients with HER2-positive malignancies.Patients and Methods:In a phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaab96d906f2da5fd2a148efdea4c8ed
https://doi.org/10.1158/1078-0432.c.6529842
https://doi.org/10.1158/1078-0432.c.6529842
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Purpose:RET is an estrogen response gene with preclinical studies demonstrating cross-talk between the RET and estrogen receptor (ER) pathways. We investigate the role of lenvatinib, a multikinase inhibitor with potent activity against RET, in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e493f677e970d70092bf8afa81bf17c
https://doi.org/10.1158/1078-0432.c.6532424.v1
https://doi.org/10.1158/1078-0432.c.6532424.v1
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Table from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02061fae97a0b8e77fb74d487409f1d
https://doi.org/10.1158/1078-0432.22486937
https://doi.org/10.1158/1078-0432.22486937
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Data from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00fc277da44ab4288b38054c7a7e0c6
https://doi.org/10.1158/1078-0432.22486946
https://doi.org/10.1158/1078-0432.22486946
Autor:
Soo-Chin Lee, Boon Cher Goh, Bee Choo Tai, Lingzhi Wang, Supriya Jain, Kritika Yadav, Raghav Sundar, Cheng Ean Chee, David S.P. Tan, Ross A. Soo, Wei Peng Yong, Hon Lyn Tan, Joan R.E. Choo, Matilda Lee, Yi Wan Lim, Siew Eng Lim, Wan Qin Chong, Yvonne L.E. Ang, Gloria H.J. Chan, Natalie Y.L. Ngoi, Samuel G.W. Ow, Andrea L.A. Wong, Joline S.J. Lim
Supplementary Figure from Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51301d328c110373e6f3c2828ea93958
https://doi.org/10.1158/1078-0432.22486943
https://doi.org/10.1158/1078-0432.22486943
Autor:
Dario Campana, Boon Cher Goh, Priscillia J.X. Koe, Jedidah L.M. Lieow, Nesaretnam Barr Kumarakulasinghe, Wan Qin Chong, Hon Lyn Tan, Raghav Sundar, Elaine Coustan-Smith, Mabel Z.Q. Foo, Yoon Sim Yap, Lavina Bharwani, Samuel G.W. Ow, Sing Huang Tan, Michelle L.M. Poon, Liang Piu Koh, Lip Kun Tan, Wei Peng Yong, Kritika Yadav, Andrea Wong, Joline S.J. Lim, Noriko Shimasaki, Soo-Chin Lee
Supplementary Materials, Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0209f96b4c5f79fd3d29bd1e4c30823
https://doi.org/10.1158/1078-0432.22478064
https://doi.org/10.1158/1078-0432.22478064
Autor:
Joline S.J. Lim, Andrea L.A. Wong, Samuel G.W. Ow, Natalie Y.L. Ngoi, Gloria H.J. Chan, Yvonne L.E. Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda Lee, Joan R.E. Choo, Hon Lyn Tan, Wei Peng Yong, Ross A. Soo, David S.P. Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Lingzhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(11)
Purpose: RET is an estrogen response gene with preclinical studies demonstrating cross-talk between the RET and estrogen receptor (ER) pathways. We investigate the role of lenvatinib, a multikinase inhibitor with potent activity against RET, in patie
Autor:
Siew Eng Lim, Yi Wan Lim, Jeffrey Low, Samuel Guan Wei Ow, Soo-Chin Lee, Pei Yi Ong, Hwai Loong Kong, David S.P. Tan, Gloria Chan
Publikováno v:
Oncotarget
// Gloria H.J. Chan 1, * , Pei Yi Ong 1, * , Jeffrey J.H. Low 2 , Hwai Loong Kong 1 , Samuel G.W. Ow 1 , David S.P. Tan 1, 3 , Yi Wan Lim 1 , Siew Eng Lim 1 and Soo-Chin Lee 1, 3 1 Department of Haematology-Oncology, National University Cancer Instit
Autor:
Shaik Ahmad Buhari, Philip Iau, Lingzhi Wang, Samuel Guan Wei Ow, Andrea Li Ann Wong, Thomas I Peng Soh, Yiqing Huang, Tingting Wang, Chee Seng Tan, Boon Cher Goh, Soo-Chin Lee, Angela S.L. Pang, Jingshan Ho, Jannet Mogro, Anand D. Jeyasekharan, Mikael Hartman, Choon Hua Thng, Thian-C Ng, Raghav Sundar, Ching Wan Chan, Bo Zhang, Sing-Huang Tan
Publikováno v:
Oncotarget
// Andrea L.A. Wong 1, 2, 3 , Raghav Sundar 1, 2 , Ting-Ting Wang 3 , Thian-C Ng 4 , Bo Zhang 4 , Sing-Huang Tan 1, 2 , Thomas I.P. Soh 1, 2 , Angela S.L. Pang 1, 2 , Chee-Seng Tan 1, 2 , Samuel G.W. Ow 1, 2 , Lingzhi Wang 3, 5 , Jannet Mogro 2 , Jin
Autor:
Ngoi NYL; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Tay D; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Heong V; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Thian YL; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Ong PY; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Ow SGW; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Jeyasekharan AD; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Lim YW; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Lim SE; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Lee SC; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Ng J; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Low JJH; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Ilancheran A; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Koh SZL; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore., Tan DSP; Natalie Y.L. Ngoi, Valerie Heong, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, and David S.P. Tan, National University Cancer Institute; Darwin Tay, Valerie Heong, Anand D. Jeyasekharan, Soo Chin Lee, and David S.P. Tan, National University of Singapore; Yee Liang Thian, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, and Sharon Z.L. Koh, National University Hospital, Singapore, Republic of Singapore.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2018 Nov; Vol. 2, pp. 1-8.